$2.44
0.000.00%
À la fermeture: -
$2.47
0.031.23%
Après les heures de négociation: Aug 15, 7:52 PM EDT
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Cardiff Oncology Inc (NASDAQ:CRDF) a diminué lors de la dernière période de déclaration, augmentant de en baisse de 18.90M à 18.84M. Cela représente 29.08% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Cardiff Oncology Corp (XNAS:CRDF) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 3.91M actions échangées par jour, il faudrait 4.81 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
18.84M
Intérêt à court terme %
29.1%
Jours de couverture
4.81
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
CRDF | Cardiff Oncology, Inc. Common | 07/31/2025 | 08/11/2025 | 29.08% | 64,792,620 | 18,840,200 | 3,914,321 | 4.81 | |
CRDF | Cardiff Oncology, Inc. Common | 07/15/2025 | 07/24/2025 | 29.16% | 64,792,620 | 18,896,208 | 1,327,804 | 14.23 | |
CRDF | Cardiff Oncology, Inc. Common | 06/30/2025 | 07/10/2025 | 28.37% | 64,792,620 | 18,379,006 | 1,515,278 | 12.13 | |
CRDF | Cardiff Oncology, Inc. Common | 06/13/2025 | 06/25/2025 | 26.68% | 64,792,620 | 17,289,872 | 1,188,312 | 14.55 | |
CRDF | Cardiff Oncology, Inc. Common | 05/30/2025 | 06/10/2025 | 27.22% | 64,792,620 | 17,633,640 | 860,418 | 20.49 | |
CRDF | Cardiff Oncology, Inc. Common | 05/15/2025 | 05/27/2025 | 27.04% | 64,792,620 | 17,522,454 | 771,741 | 22.71 | |
CRDF | Cardiff Oncology, Inc. Common | 04/30/2025 | 05/09/2025 | 26.78% | 65,252,772 | 17,475,197 | 1,085,687 | 16.1 | |
CRDF | Cardiff Oncology, Inc. Common | 04/15/2025 | 04/25/2025 | 26.57% | 65,252,772 | 17,336,093 | 1,791,208 | 9.68 | |
CRDF | Cardiff Oncology, Inc. Common | 03/31/2025 | 04/09/2025 | 22.70% | 65,252,772 | 14,812,856 | 1,114,184 | 13.29 | |
CRDF | Cardiff Oncology, Inc. Common | 03/14/2025 | 03/25/2025 | 20.45% | 65,252,772 | 13,341,326 | 1,138,915 | 11.71 | |
CRDF | Cardiff Oncology, Inc. Common | 02/28/2025 | 03/11/2025 | 17.44% | 65,252,772 | 11,382,589 | 1,248,577 | 9.12 | |
CRDF | Cardiff Oncology, Inc. Common | 02/14/2025 | 02/26/2025 | 16.61% | 65,252,772 | 10,840,447 | 848,495 | 12.78 | |
CRDF | Cardiff Oncology, Inc. Common | 01/31/2025 | 02/11/2025 | 16.02% | 65,252,772 | 10,451,856 | 942,180 | 11.09 | |
CRDF | Cardiff Oncology, Inc. Common | 01/15/2025 | 01/27/2025 | 14.52% | 65,252,772 | 9,475,951 | 1,285,978 | 7.37 | |
CRDF | Cardiff Oncology, Inc. Common | 12/31/2024 | 01/10/2025 | 14.57% | 65,252,772 | 9,507,049 | 1,925,558 | 4.94 | |
CRDF | Cardiff Oncology, Inc. Common | 12/13/2024 | 12/24/2024 | 15.24% | 65,252,772 | 9,947,769 | 6,708,939 | 1.48 | |
CRDF | Cardiff Oncology, Inc. Common | 11/29/2024 | 12/10/2024 | 16.40% | 49,862,337 | 8,179,403 | 512,963 | 15.95 | |
CRDF | Cardiff Oncology, Inc. Common | 11/15/2024 | 11/26/2024 | 15.47% | 49,862,337 | 7,715,250 | 1,354,532 | 5.7 | |
CRDF | Cardiff Oncology, Inc. Common | 10/31/2024 | 11/11/2024 | 17.82% | 45,278,224 | 8,068,093 | 844,232 | 9.56 | |
CRDF | Cardiff Oncology, Inc. Common | 10/15/2024 | 10/24/2024 | 16.16% | 45,278,224 | 7,315,126 | 532,649 | 13.73 | |
CRDF | Cardiff Oncology, Inc. Common | 09/30/2024 | 10/09/2024 | 15.08% | 45,278,224 | 6,826,675 | 538,851 | 12.67 | |
CRDF | Cardiff Oncology, Inc. Common | 09/13/2024 | 09/24/2024 | 15.23% | 45,278,224 | 6,895,922 | 427,144 | 16.14 | |
CRDF | Cardiff Oncology, Inc. Common | 08/30/2024 | 09/11/2024 | 15.25% | 45,278,224 | 6,902,749 | 275,991 | 25.01 | |
CRDF | Cardiff Oncology, Inc. Common | 08/15/2024 | 08/26/2024 | 14.83% | 45,278,224 | 6,716,616 | 542,814 | 12.37 | |
CRDF | Cardiff Oncology, Inc. Common | 07/31/2024 | 08/09/2024 | 13.30% | 43,465,781 | 5,783,089 | 348,164 | 16.61 | |
CRDF | Cardiff Oncology, Inc. Common | 07/15/2024 | 07/24/2024 | 11.78% | 43,465,781 | 5,120,098 | 646,975 | 7.91 | |
CRDF | Cardiff Oncology, Inc. Common | 06/28/2024 | 07/10/2024 | 9.71% | 43,465,781 | 4,221,987 | 1,198,251 | 3.52 | |
CRDF | Cardiff Oncology, Inc. Common | 06/14/2024 | 06/26/2024 | 9.29% | 43,465,781 | 4,038,360 | 480,297 | 8.41 | |
CRDF | Cardiff Oncology, Inc. Common | 05/31/2024 | 06/11/2024 | 10.26% | 43,465,781 | 4,460,469 | 415,416 | 10.74 | |
CRDF | Cardiff Oncology, Inc. Common | 05/15/2024 | 05/24/2024 | 10.64% | 43,453,181 | 4,622,586 | 847,125 | 5.46 | |
CRDF | Cardiff Oncology, Inc. Common | 04/30/2024 | 05/09/2024 | 10.17% | 43,453,181 | 4,418,167 | 771,544 | 5.73 | |
CRDF | Cardiff Oncology, Inc. Common | 04/15/2024 | 04/24/2024 | 9.18% | 43,438,981 | 3,987,551 | 908,765 | 4.39 | |
CRDF | Cardiff Oncology, Inc. Common | 03/28/2024 | 04/09/2024 | 7.86% | 43,404,052 | 3,410,807 | 1,439,761 | 2.37 | |
CRDF | Cardiff Oncology, Inc. Common | 03/15/2024 | 03/26/2024 | 6.48% | 43,404,052 | 2,813,413 | 7,259,168 | 1 | |
CRDF | Cardiff Oncology, Inc. Common | 02/29/2024 | 03/11/2024 | 2.66% | 43,404,052 | 1,154,889 | 317,561 | 3.64 | |
CRDF | Cardiff Oncology, Inc. Common | 02/15/2024 | 02/27/2024 | 2.74% | 43,404,052 | 1,187,491 | 282,564 | 4.2 | |
CRDF | Cardiff Oncology, Inc. Common | 01/31/2024 | 02/09/2024 | 2.97% | 43,404,052 | 1,291,018 | 91,930 | 14.04 | |
CRDF | Cardiff Oncology, Inc. Common | 01/12/2024 | 01/24/2024 | 2.63% | 43,404,052 | 1,143,348 | 158,273 | 7.22 | |
CRDF | Cardiff Oncology, Inc. Common | 12/29/2023 | 01/10/2024 | 3.03% | 43,404,052 | 1,317,040 | 167,461 | 7.86 | |
CRDF | Cardiff Oncology, Inc. Common | 12/15/2023 | 12/27/2023 | 3.11% | 43,404,052 | 1,350,141 | 137,674 | 9.81 | |
CRDF | Cardiff Oncology, Inc. Common | 11/30/2023 | 12/11/2023 | 3.33% | 43,404,052 | 1,446,750 | 130,184 | 11.11 | |
CRDF | Cardiff Oncology, Inc. Common | 11/15/2023 | 11/27/2023 | 3.68% | 43,404,052 | 1,595,328 | 252,305 | 6.32 | |
CRDF | Cardiff Oncology, Inc. Common | 10/31/2023 | 11/09/2023 | 3.75% | 43,404,052 | 1,626,822 | 249,789 | 6.51 | |
CRDF | Cardiff Oncology, Inc. Common | 10/13/2023 | 10/24/2023 | 3.52% | 43,404,052 | 1,528,003 | 469,250 | 3.26 | |
CRDF | Cardiff Oncology, Inc. Common | 09/29/2023 | 10/10/2023 | 4.67% | 43,404,052 | 2,028,820 | 3,095,548 | 1 | |
CRDF | Cardiff Oncology, Inc. Common | 09/15/2023 | 09/26/2023 | 1.55% | 43,404,052 | 673,005 | 203,123 | 3.31 | |
CRDF | Cardiff Oncology, Inc. Common | 08/31/2023 | 09/12/2023 | 1.24% | 43,404,052 | 536,446 | 148,057 | 3.62 | |
CRDF | Cardiff Oncology, Inc. Common | 08/15/2023 | 08/24/2023 | 1.54% | 43,404,052 | 666,349 | 2,584,302 | 1 |
À la recherche des actions les plus vendues à découvert?